Indication

H. influenzae meningitis

*H. Read more about H. influenzae meningitis

133 drugs 56 manufacturers

Advertisement

Drugs that treat it

Common H. influenzae meningitis therapies.

Showing 73–81 of 133 drugs

MEROPENEM

MENINGOCOCCAL MENINGITIS·+21
APP/FRESENIUS K

MEROPENEM

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+21
AMNEAL BIOSCIEN
Filter & compare in the drug finder →Opens the drug finder with H. influenzae meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About H. influenzae meningitis.

*H.

influenzae* meningitis is a severe, life-threatening bacterial infection characterized by acute purulent inflammation of the meninges surrounding the brain and spinal cord.

Caused by the gram-negative coccobacillus *Haemophilus influenzae*—historically most often encapsulated serotype b (Hib)—it primarily targets infants, children under five years of age, and immunocompromised or asplenic individuals following hematogenous dissemination from the upper respiratory tract.

Hallmarks of the disease include high fever, severe headache, nuchal rigidity, photophobia, altered mental status, and, in infants, poor feeding, lethargy, and bulging fontanelles.

Without prompt intervention, the inflammatory response in the subarachnoid space can lead to elevated intracranial pressure, subdural effusions, irreversible sensorineural hearing loss, or death.

Personalize your experience

Follow H. influenzae meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it